Christopher R. Flowers, MD, MS

Associate Professor, Hematology & Medical Oncology

Emory University School of Medicine

Director, Emory Lymphoma Program

Winship Cancer Institute of Emory University

Scientific Director, Winship Research Informatics

Winship Cancer Institute of Emory University

Office: The Emory Clinic, Bldg. B

Phone: (404) 778-3942

Fax: (404) 778-3366



Dr. Christopher Flowers graduated from Stanford University from the Human Biology and Humanities honors programs. He remained at Stanford where he completed medical school and a master's degree in Medical Information Sciences. After medical school, he returned to Seattle where he completed internal medicine residency at the University of Washington. After residency, Dr. Flowers continued his research training in Seattle through the Robert Wood Johnson Clinical Scholars Program and oncology fellowship at the Fred Hutchinson Cancer Research Center. At the University of Washington, he collaborated on studies that investigated the cost effectiveness of pharmacogenomics in oncology, and developed clinical and translational studies in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.

Dr. Flowers serves as Clinical Director for the Oncology Informatics Program, and is a member of the Emory Stem Cell and Bone Marrow Transplant team. He also directs the lymphoma clinic at Emory. His clinic focuses on specialized care for patients with lymphoid malignancies involving multi-specialty input from hematopathologists, immunologists, surgeons, radiation oncologists, and specialists in nuclear medicine and bone marrow transplantation. Through the lymphoma clinic, Dr. Flowers offers a variety of clinical trials and advanced treatment algorithms for patients with lymphoma.

Dr. Flowers is a member of the Cancer Prevention and Control Research Program at Winship Cancer Institute of Emory University.

Full Clinical Bio >>


Dr. Flowers' current research projects span three areas: 1) translational research clinical trials in non-Hodgkin's Lymphoma, 2) oncology informatics projects developing an information infrastructure to support pharmacogenomics and outcomes research, and 3) medical decision analyses and cost-effectiveness analyses aimed at developing strategies to individualize care for cancer patients.


Clinical Trials

View clinical trials at Winship Cancer Institute